Menu
Search
|

Menu

Close
X

Lonza Group AG LONN.S (Virt-X Level 1)

288.00 CHF
-- (--)
As of Jul 17
chart
Previous Close 288.00
Open --
Volume --
3m Avg Volume 327,309
Today’s High --
Today’s Low --
52 Week High 290.70
52 Week Low 212.90
Shares Outstanding (mil) 74.47
Market Capitalization (mil) 21,501.14
Forward P/E 27.92
Dividend (Yield %) 2.75 ( 0.95 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 12 analysts

KEY STATS

Revenue (mm, CHF)
FY17
5,105
FY16
4,132
FY15
3,803
EPS (CHF)
FY17
10.329
FY16
5.287
FY15
4.868
*Note: Units in Millions of Swiss Francs
**Note: Units in Swiss Francs

KEY RATIOS

Price to Earnings (TTM)
vs sector
27.92
33.15
Price to Sales (TTM)
vs sector
4.21
8.04
Price to Book (MRQ)
vs sector
3.44
4.28
Price to Cash Flow (TTM)
vs sector
--
22.37
Total Debt to Equity (MRQ)
vs sector
68.43
17.43
LT Debt to Equity (MRQ)
vs sector
60.11
13.25
Return on Investment (TTM)
vs sector
8.68
13.23
Return on Equity (TTM)
vs sector
16.96
15.27

EXECUTIVE LEADERSHIP

Rolf Soiron
Chairman of the Board of Directors, Since 2012
Salary: --
Bonus: --
Richard Ridinger
Chief Executive Officer and Member of the Executive Committee, Since 2012
Salary: CHF965,000.00
Bonus: --
Albert M Baehny
Vice Chairman of the Board, Since 2017
Salary: --
Bonus: --
Rodolfo Savitzky
Chief Financial Officer, Member of the Executive Committee, Since 2016
Salary: --
Bonus: --
Sven Abend
Chief Operating Officer - Specialty Ingredients, Member of the Management Board, Chief Strategy Officer, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

Muenchensteinerstrasse 38
BASEL     4052

Phone: +4161.3168111

Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.

SPONSORED STORIES